TY - JOUR
T1 - Atopic Dermatitis and the Role of the Skin Microbiome in Choosing Prevention, Treatment, and Maintenance Options
AU - Baldwin, Hilary
AU - Aguh, Crystal
AU - Andriessen, Anneke
AU - Benjamin, Latanya
AU - Farberg, Aaron S.
AU - Hooper, Deirdre
AU - Jorizzo, Joseph L.
AU - Lio, Peter A.
AU - Tlougan, Brook
AU - Woolery-Lloyd, Heather C.
AU - Zeichner, Joshua
N1 - Funding Information:
This review was supported by an unrestricted educational grant from La Roche-Posay Dermatological Laboratories, USA.
Publisher Copyright:
Copyright © 2020.
PY - 2020/10
Y1 - 2020/10
N2 - Background: Atopic dermatitis (AD) is a common skin condition characterized by disturbed barrier function, skin inflammation, and cutaneous dysbiosis. Clinically, it manifests as chronic-recurrent xerosis, pruritus, and erythematous lesions. Its pathophysiology is complex, making the selection of appropriate treatment optio ns a task. Aim: To share insights gained from a literature review and discussions with experts in dermatology on key factors related to the prevention, treatment, and management of AD in relation to the skin microbio me. Methods: Results from an expert panel were summarized and discussed to provide updated recommendations for the treatment and maintenance of AD. Results: Evidence supports a strategy for managing inflammatory skin diseases with a selenium-rich post-biotic thermal water and biomass containing moisturizer. The moisturizer helps to restore homeostasis of the skin, re-populate a diverse microbiome, encourage the growth of commensal bacteria, and improve barrier function and symptoms of AD. Conclusions: Normalization of skin microbiome diversity using a topical moisturizer containing post-biotic aqua and biomass may offer a valuable option for the treatment and maintenance of inflammatory skin diseases. Clinicians should discuss the benefits of this treatment in the context of a full AD management program that covers prevention, active treatment, and maintenance.
AB - Background: Atopic dermatitis (AD) is a common skin condition characterized by disturbed barrier function, skin inflammation, and cutaneous dysbiosis. Clinically, it manifests as chronic-recurrent xerosis, pruritus, and erythematous lesions. Its pathophysiology is complex, making the selection of appropriate treatment optio ns a task. Aim: To share insights gained from a literature review and discussions with experts in dermatology on key factors related to the prevention, treatment, and management of AD in relation to the skin microbio me. Methods: Results from an expert panel were summarized and discussed to provide updated recommendations for the treatment and maintenance of AD. Results: Evidence supports a strategy for managing inflammatory skin diseases with a selenium-rich post-biotic thermal water and biomass containing moisturizer. The moisturizer helps to restore homeostasis of the skin, re-populate a diverse microbiome, encourage the growth of commensal bacteria, and improve barrier function and symptoms of AD. Conclusions: Normalization of skin microbiome diversity using a topical moisturizer containing post-biotic aqua and biomass may offer a valuable option for the treatment and maintenance of inflammatory skin diseases. Clinicians should discuss the benefits of this treatment in the context of a full AD management program that covers prevention, active treatment, and maintenance.
UR - http://www.scopus.com/inward/record.url?scp=85092683480&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85092683480&partnerID=8YFLogxK
U2 - 10.36849/JDD.2020.5393
DO - 10.36849/JDD.2020.5393
M3 - Article
C2 - 33026777
AN - SCOPUS:85092683480
SN - 1545-9616
VL - 19
SP - 935
EP - 940
JO - Journal of Drugs in Dermatology
JF - Journal of Drugs in Dermatology
IS - 10
ER -